/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | HSCSWHeartSciences Inc. |
|---|---|
| Last close | $0.08close 2026-11-06 |
| Change % | -24.05%close 2026-11-06 |
| Market cap | $388813.93200000003close 2026-11-06 |
| P/E | loss, no P/E |
| Revenue | $4319⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -0.7%FY to 2026-04-30 |
| Net income | $-9141875⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2026-04-30 Filing10-K · 0001437749-26-024337 · filed 2026-07-23 Open the filing on EDGAR →Open the XBRL payload →CiteHeartSciences Inc. (HSCSW), us-gaap:NetIncomeLoss: -9,141,875 USD, fiscal year ended 2026-04-30. Form 10-K, accession 0001437749-26-024337, filed 2026-07-23. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001468492/us-gaap/NetIncomeLoss.json |
| Net margin | -211666.5%FY to 2026-04-30 |
| EPS (diluted) | $-9.34⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-04-30 Filing10-K · 0000950170-25-098326 · filed 2025-07-24 Open the filing on EDGAR →Open the XBRL payload →CiteHeartSciences Inc. (HSCSW), us-gaap:EarningsPerShareDiluted: -9.34 USD per share, fiscal year ended 2025-04-30. Form 10-K, accession 0000950170-25-098326, filed 2025-07-24. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001468492/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 3FY to 2026-04-30 |
| Altman Z-ScoreUNVALIDATED | -28.43FY to 2026-04-30 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | 12-09 → 12-19 |